Found 724 matching trials
Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction PHASE4 Cardiac magnetic resonance imaging (MRI) measures of myocardial interstitia...
Show More Location
Multiple Locations
Learn More & Join Trial
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer PHASE2 In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction N/A Study Aim is creation of the Hospital Register of patients with heart failu...
Show More Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Learn More & Join Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors PHASE2 Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare
Learn More & Join Trial
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) PHASE1 This is a phase 1b study, which means that the purpose of the study is to e...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The Second Affiliated Hospital of SchoowUniversity
Learn More & Join Trial
Abscopal Effect for Metastatic Small Cell Lung Cancer PHASE2 Patients with small cell lung cancer that had metastatic lesions after been...
Show More Location
Multiple Locations
Learn More & Join Trial